FDA Inspection 964885 — Department of Defense - Army

Department of Defense - Army — FEI 2977443

The FDA completed an inspection of Department of Defense - Army on March 28, 2016 in Tripler Army Medical Center, HI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 28, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Tripler Army Medical Center, HI (United States)